Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | P4HB | P07237 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | GRK2 | P25098 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25001338 | 0.89 | KMT2A (0.60) | PAX8KMT2AALDH1A1LMNAMAPK1 | |
| SCHEMBL25002673 | 0.81 | KMT2A (0.65) | PAX8KMT2AALDH1A1LMNAMAPK1 | |
| SCHEMBL29275318 | 0.71 | HSD11B1 (0.78) | PAX8KMT2AALDH1A1LMNAMAPK1 | |
| SCHEMBL23480400 | 0.71 | KMT2A (0.69) | PAX8KMT2AALDH1A1LMNAMAPK1 | |
| SCHEMBL7874157 | 0.71 | KMT2A (0.71) | PAX8KMT2AALDH1A1LMNAMAPK1 | |
| SCHEMBL27113450 | 0.70 | CNR2 (0.49) | ALDH1A1LMNATSHRGAAMAPT | |
| SCHEMBL1951415 | 0.70 | KMT2A (0.76) | PAX8KMT2AALDH1A1LMNAMAPK1 | |
| SCHEMBL25128778 | 0.70 | KMT2A (0.76) | PAX8KMT2AALDH1A1LMNAMAPK1 | |
| SCHEMBL21541110 | 0.70 | KMT2A (0.70) | PAX8KMT2AALDH1A1LMNAMAPK1 | |
| SCHEMBL21033276 | 0.70 | KMT2A (0.69) | PAX8KMT2AALDH1A1LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230039858-A1 | COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION | INTOCELL, INC. (KR) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230039858-A1 | COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION | FCGR2A, FCGRT, FCGR3B | PAX8 4289/4885KMT2A 832/4885ALDH1A1 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.